missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human EOGT (aa 20-152) Control Fragment Recombinant Protein
Description
Highest antigen sequence indentity to the following orthologs: Mouse (74%), Rat (74%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-53990 (PA5-53990. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
The exact function of C3orf64 remains unknown.
Specifications
Specifications
| Accession Number | Q5NDL2 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 285203 |
| Name | Human EOGT (aa 20-152) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | A130022J15Rik; Aer61; AER61 glycosyltransferase; AI447490; AOS4; AW214473; AW259391; C3orf64; EGF domain specific O-linked N-acetylglucosamine transferase; EGF domain-specific O-linked N-acetylglucosamine (GlcNAc) transferase; EGF domain-specific O-linked N-acetylglucosamine transferase; EGF-O-GlcNAc transferase; EOGT; EOGT1; Extracellular O-linked N-acetylglucosamine transferase; glycosyltransferase Aer61 |
| Common Name | EOGT |
| Show More |